MyOme is a company developing a whole genome analysis platform to help people understand their risk for inherited diseases. It offers whole genome sequencing, single gene analysis, and polygenic analysis to assess the risk of multifactorial diseases. The company also uses artificial intelligence, machine learning technologies, and analysis methods to provide integrated disease risk scores.